Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Heart Failure
Clinical trial register · China

Heart Failure Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19212 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:17 UTC
19212
Studies in scope
all four open statuses
11805
Recruiting now
open to new participants
2029
Lead sponsors
across recruiting studies
Top sites
Beijing 25 Shanghai 20 Guangzhou 12 Nanjing 11 Changsha 9
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Jiangsu Taizhou People's Hospital7 Ruijin Hospital5 Second Affiliated Hospital, Zhejiang University, School of Medicine4 HELP Therapeutics Co., Ltd.3 Heart Health Research Center3
Site location
Beijing25 Shanghai20 Guangzhou12 Nanjing11 Changsha9
All 65 locations
Target enrolment
to

Heart Failure trials in China

78 of 19212 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Heart Health Research Center
Not applicable
588
Ruyang
2026-10-15
Not yet open
Jiangsu Taizhou People's Hospital
Not applicable
1,200
Lianyungang
2026-10-10
Recruiting
Jiangsu Taizhou People's Hospital
Not applicable
2,532
Nanjing
2026-10-01
Recruiting
Tasly Pharmaceutical Group Co., Ltd
Phase 3
636
Bozhou, Hefei, Suzhou, Beijing, Fuzhou, Lanzhou, Qingyang, Dongguan
2026-08-21
Not yet open
Medical Large Language Model-Assisted Diagnosis and Treatment in Primary Care Chronic Disease Management
NCT07740044Coronary Artery Disease, Atrial Fibrillation (AF), Heart Failure, Stroke
Jiangsu Taizhou People's Hospital
Not applicable
20
Taizhou
2026-08-17
Recruiting
Jiangsu Taizhou People's Hospital
Not applicable
1,356
Yancheng, Yangzhou, Xuzhou
2026-07-26
Recruiting
Jiangsu Taizhou People's Hospital
Not applicable
942
Yancheng, Yangzhou, Xuzhou
2026-07-26
Recruiting
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1/2
108
Nanjing, Hangzhou, Ha’erbin, Huai'an, Zhengzhou
2026-07-01
Recruiting
Shandong Suncadia Medicine Co., Ltd.
Phase 1
66
Shanghai
2026-06-12
Recruiting
Chengdu Suncadia Medicine Co., Ltd.
Phase 1
74
Beijing
2026-05-20
Not yet open
China National Center for Cardiovascular Diseases
Phase 4
104
Beijing
2026-05-15
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Guangzhou, Shijiazhuang, Harbin, Changsha, Baotou, Changzhou, Nanjing, Suzhou
2026-05-11
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
5
Hangzhou
2026-05-11
Not yet open
RDN for Heart Failure
NCT07558902Heart Failure
Shanghai Golden Leaf MedTec Co. Ltd
Not applicable
20
Shanghai
2026-05-10
Recruiting
HELP Therapeutics Co., Ltd.
Phase 3
80
Tianjin
2026-04-30
Not yet open
Bachmann Bundle Pacing for Prevention of New-Onset Atrial Fibrillation in Patients With Heart Failure
NCT07547449Heart Failure, Atrial Fibrillation (AF), Cardiac Insufficiency
Fu Wai Hospital, Beijing, China
Not applicable
140
Beijing
2026-04
Recruiting
United Innomed(Shanghai) Limited
Not applicable
330
Fuzhou, Lanzhou, Guangzhou, Guiyang, Zhengzhou, Changsha, Nanchang, Shanghai
2026-03-16
Recruiting
Construction of a Cohort of Elderly Patients With Atrial Fibrillation in Rural China
NCT07611084Atrial Fibrillation (AF), Heart Failure, Screening, Progression
Jiangsu Taizhou People's Hospital
Observational
2,500
Taizhou
2026-03-14
Recruiting
National Defense Medical Center, Taiwan
Observational
5,000
2026-03-01
Recruiting
Sinotau Pharmaceutical Group
Phase 2
40
Beijing, Tianjin
2025-12-18
Not yet open
Zhongda Hospital
Observational
200
Nanjing
2025-12-01
Not yet open
First Hospital of China Medical University
Observational
2,640
Chongqing, Shenzhen, Shijiazhuang, Harbin, Zhengzhou, Wuhan, Xiangyang, Changchun
2025-12
Recruiting
RenJi Hospital
Not applicable
10
Shanghai
2025-11-28
Recruiting
Biomarkers for Left Ventricular Reverse Remodeling in Heart Failure (REVERT-HF)
NCT07701876Heart Failure, Heart Failure and Reduced Ejection Fraction
Ruijin Hospital Luwan Branch
Observational
1,740
Shanghai
2025-11-01
Not yet open
Beijing Suncadia Pharmaceuticals Co., Ltd
Phase 1
48
Beijing
2025-11
Recruiting
The University of Hong Kong
Not applicable
208
Shanghai
2025-09-15
Recruiting
Chinese Academy of Medical Sciences, Fuwai Hospital
Observational
1,000
Beijing
2025-08-01
Recruiting
Pfizer
Phase 2
620
Beijing, Lanzhou, Guangzhou, Haikou, Shijiazhuang, Changsha, Changchun, Xi'an
2025-06-19
Recruiting
Guangdong Provincial People's Hospital
Not applicable
118
Guangzhou
2025-06-01
By invitation
The Safety and Efficacy of Pulsed Field Ablation for Patients With Persistent Atrial Fibrillation Comorbid With HFpEF.
NCT07077811Cardiovascular Diseases, Heart Failure, Atrial Fibrillation (AF), HFpEF - Heart Failure With Preserved Ejection Fraction
Affiliated Hospital of Nantong University
Not applicable
158
Nantong
2025-06-01
Recruiting
Boehringer Ingelheim
Phase 3
4,200
Beijing, Changchun, Changde, Changsha, Chengdu, Chenzhou, Chongqing, Dalian
2025-05-20
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1/2
43
Hangzhou
2025-04-22
Recruiting
Heart Health Research Center
Not applicable
1,301
Beijing
2025-04-03
Not yet open
Efficacy and Safety of Early Initiation of Vericiguat in Heart Failure After Acute Myocardial Infarction
NCT06812546Heart Failure, Acute Myocardial Infarction (AMI), Acute Heart Failure (AHF)
DrugVericiguat
Dongying Zhang
Phase 4
200
Chongqing
2025-04-01
Recruiting
AstraZeneca
Phase 3
11,300
Baotou, Beijing, Changchun, Changde, Changsha, Changzhou, Chengdu, Chifeng
2025-03-14
Recruiting
Mechanisms And Prognosis of Stroke-Heart Syndrome
NCT06954103Stroke, Myocardial Injury, Heart Failure, Acute Coronary Syndromes
Chensheng Pan
Observational
658
Wuhan
2025-03-01
Not yet open
IPSC-CMs Combined with LVAD or CABG for the Treatment of Heart Failure
NCT06866600Heart Failure, Heart Failure At NYHA Stage III or IV
HELP Therapeutics Co., Ltd.
Phase 1/2
40
Nanjing
2025-03
Not yet open
Tasly Pharmaceutical Group Co., Ltd
Phase 2
288
Tianjin
2025-01-31
Recruiting
Community Exercise Treating Effect on Cardiopulmonary Disease Patients
NCT07154355Coronary Heart Disease (CHD), Heart Failure, Cardiomyopathy, COPD
Guangdong Provincial People's Hospital
Not applicable
200
Guangzhou
2025-01-30
Recruiting
Cytokinetics
Phase 3
1,800
Beijing, Chongqing, Lanzhou, Guangzhou, Shenzhen, Nanning, Harbin, Luoyang
2024-12-19
Recruiting
Evaluating the Safety and Effectiveness of 5G Cloud Follow-up for Cardiovascular Implantable Electronic Devices
NCT06652750Sick Sinus Syndrome, Atrioventricular Block, Second and Third Degree, Heart Failure
The Third People's Hospital of Chengdu
Not applicable
688
Guangzhou, Chengdu
2024-11-13
By invitation
Ruijin Hospital
Observational
266
Shanghai
2024-10-01
Active, closed
Bolt CSP-M Holter Study
NCT06540521Heart Failure, Bradycardia
Medtronic Cardiac Rhythm and Heart Failure
Observational
95
Shanghai, Hangzhou
2024-08-13
Recruiting
Mechanisms of Brain-Heart Injury of Post-Intracranial Hemorrhage
NCT06906432Subarachnoid Hemorrhage, Aneurysmal, Cerebrocardiac Syndrome, Mass Spectrometry, Heart Failure
Beijing Tiantan Hospital
Observational
1,000
Beijing
2024-08-01
Recruiting
Colorado Prevention Center
Phase 3
1,500
Guangzhou, Changsha, Jinan, Shanghai, Taiyuan, Xian City, Chengdu, Tianjin
2024-07-09
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Baotou, Beijing, Changchun, Changde, Changsha, Chengdu, Chenzhou, Dalian
2024-06-17
Recruiting
Mobile Applet for Weight Management in Obese Heart Failure Patients
NCT06455878Heart Failure, Overweight and Obesity, Weight Loss, Heart Failure With Reduced Ejection Fraction
Heart Health Research Center
Not applicable
830
Beijing, Guangzhou, Langfang, Jixi, Luoyang, Shangqiu, Xinyang, Zhengzhou
2024-06-06
By invitation
Artificial Intelligence in Detecting Cardiac Function
NCT06444425Heart Failure, Deep Learning
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Observational
685
Yiwu
2024-06-01
Recruiting
Clinical Outcomes of Cardiovascular Disease
NCT06459934Cardiovascular Diseases, Heart Failure, Coronary Artery Disease
Xinjiang Medical University
Observational
30,000
Ürümqi
2024-06-01
Recruiting
Second Affiliated Hospital of Nanchang University
Not applicable
100
Nanchang
2024-03-01
Recruiting
Village-Based Management of Chronic Cardiovascular Disease in Qu Jiang Elderly Population Registry: The BOUQUET Cohort Study
NCT07149688Atrial Fibrillation (AF), Hypertension, Coronary Heart Disease (CHD), Heart Failure
Beijing Anzhen Hospital
Observational
30,000
Beijing
2024-03-01
Not yet open
Nanjing First Hospital, Nanjing Medical University
Not applicable
30
Nanjing
2024-02-10
By invitation
Shanghai Jiao Tong University School of Medicine
Observational
1,000
Shanghai
2023-12-01
Active, closed
Bristol-Myers Squibb
Phase 2
227
Beijing, Guangzhou, Luoyang, Changsha, Hangzhou
2023-11-07
By invitation
Identification and Functional Study of Novel Biomarkers for Cardiovascular Diseases
NCT06690684Angiocardiography, Heart Failure, Ischemic Heart Disease, Acute Myocardial Infarction (AMI)
Ya-Wei Xu
Observational
300
Shanghai
2023-10-17
Recruiting
China-Japan Friendship Hospital
Phase 4
114
Beijing
2023-10-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Not applicable
86
Nanjing
2023-09-21
Active, closed
HELP Therapeutics Co., Ltd.
Phase 1/2
36
Tianjin
2023-09-05
Recruiting
Ruijin Hospital
Observational
3,000
Shanghai
2023-08-25
Active, closed
Fu Wai Hospital, Beijing, China
Not applicable
36
Beijing, Nanjing
2023-06-26
Recruiting
Cohort Study of Chronic Heart Failure
NCT05960890Heart Failure
Jiangsu Taizhou People's Hospital
Not applicable
1,000
Taizhou
2023-06-08
Recruiting
First Affiliated Hospital Xi'an Jiaotong University
Observational
1,000
Xi'an
2023-04-23
Recruiting
China-Japan Friendship Hospital
Phase 4
336
Beijing, Baoding, Qinhuangdao, Gongyi, Yangzhou, Jining, Qingdao, Changzhi
2023-03-29
Active, closed
LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB
NCT05572957Non-ischemic Cardiomyopathy, Heart Failure, Left Bundle-Branch Block
DrugGDMT
The First Affiliated Hospital with Nanjing Medical University
Not applicable
50
Beijing, Fuzhou, Nanjing, Dalian, Chengdu, Wenzhou
2022-10-14
Recruiting
Corheart 6: Long-term Cohort Study
NCT07094919Heart Failure
China National Center for Cardiovascular Diseases
Not applicable
160
Shenzhen, Zhengzhou, Wuhan, Nanjing, Beijing, Shanghai
2021-12-12
Recruiting
The Impact of Atrial Pressure Change Before and After Combined Procedure
NCT05106270Atrial Fibrillation, Heart Failure
Shanghai 10th People's Hospital
Observational
100
Shanghai
2021-11-10
Recruiting
Clinical Study of Endocardial Myocardial Biopsy
NCT05718128Myocarditis, Cardiomyopathies, Heart Failure, Cardiac Tumor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
100
Hangzhou
2021-06-01
Active, closed
Optimal Ablation Strategies for Persistent AF With HF
NCT07153718Heart Failure, Persistent Atrial Fibrillation
Xu Liu
Not applicable
300
Anqing, Wuhan, Changshu, Xuzhou, Jinan, Jining, Yuhuan, Shanghai
2021-01-01
Recruiting
Clinical Study of Impact of Different Pacing Site in Patients
NCT04931550Bradyarrhythmias, Heart Failure, Pacemaker
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
600
Hangzhou
2020-08-01
Recruiting
Baduanjin-eight-silken-movement With Self-efficacy Building for Patients With Chronic Heart Failure (BESMILE-HF Study)
NCT03180320Heart Failure NYHA Class II, Heart Failure NYHA Class III, Heart Failure
Guangdong Provincial Hospital of Traditional Chinese Medicine
Not applicable
150
Guangzhou
2018-10-22
Recruiting
Shanghai 10th People's Hospital
Observational
10,500
Shanghai
2018-01-01
Recruiting
China Extracorporeal Life Support Registry
NCT04158479Cardiogenic Shock, Cardiac Arrest, Heart Failure, Acute Respiratory Distress Syndrome
Beijing Anzhen Hospital
Observational
20,000
Beijing
2017-01-01
Recruiting
Metabolic Abnormalities, Lifestyle and Diet Pattern in Heart Failure
NCT03951311Heart Failure, Metabolic Disease
Ruijin Hospital
Observational
1,500
Shanghai
2016-06-01
Recruiting
Risk Evaluation and Management in Heart Failure
NCT02998788Heart Failure, Risk Factor, Cardiovascular
Ruijin Hospital
Observational
1,000
Shanghai
2016-06
Recruiting
Research on Optimal Diagnosis and Treatment of Cardiorenal Syndrome
NCT05397392Heart Failure, Kidney Diseases, Kidney Injury, Heart Valve Diseases
Nanjing First Hospital, Nanjing Medical University
Observational
1,200
Nanjing
2016-01
Recruiting
Cardiometabolic evalUation REgistry of Heart Failure
NCT06939985Heart Failure, Metabolic Cardiovascular Syndrome, Metabolic Diseases
Ruijin Hospital
Observational
5,000
Shanghai
2015-01-01
Recruiting
Registry of Multicenter Brain-Heart Comorbidity in China
NCT05961748Ischemic Heart Disease, Cardiac Arrest, Atrial Fibrillation, Heart Failure
Beijing Tiantan Hospital
Observational
100,000
Beijing, Fuzhou, Xiamen, Shenzhen, Harbin, Zhengzhou, Shanghai, Shanxi
2012-01-01
Recruiting
Medtronic
Observational
20,000
Beijing, Changsha, Dalian, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei
1983-01
Rows per page Showing 1–78 of 78
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 November 2026. https://priyalifescience.com/clinical-trials-china/condition/heart-failure

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,212 studies in total at the last sync on 10 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 78 of those studies listing the condition Heart Failure.

How many Heart Failure trials are recruiting in China?

54 of the 78 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:17 UTC sync. A further 13 have not yet opened recruitment, 6 are active but closed to new participants, and 5 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Heart Failure), 78 studies
PhaseStudiesRecruitingShare
Observational272034.6%
Not applicable261633.3%
Phase 38810.3%
Phase 4536.4%
Phase 1435.1%
Phase 1/2425.1%
Phase 2425.1%

Most active sponsors

Lead sponsors with the most studies (Heart Failure)
Lead sponsorStudiesRecruiting
Jiangsu Taizhou People's Hospital75
Ruijin Hospital54
Second Affiliated Hospital, Zhejiang University, School of Medicine44
Heart Health Research Center32
HELP Therapeutics Co., Ltd.31
Beijing Anzhen Hospital22
Beijing Tiantan Hospital22
Boehringer Ingelheim22
China National Center for Cardiovascular Diseases21
China-Japan Friendship Hospital22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.